BioCentury
ARTICLE | Clinical News

Zaltrap ziv-aflibercept regulatory update

November 19, 2012 8:00 AM UTC

EMA's CHMP issued a positive opinion recommending approval of Sanofi's Zaltrap ziv-aflibercept in combination with FOLFIRI chemotherapy to treat metastatic colorectal cancer (mCRC) that is resistant t...